当前位置: X-MOL 学术Cancer Prev. Res. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Epigenetics/epigenomics and prevention of early stages of cancer by isothiocyanates
Cancer Prevention Research ( IF 3.3 ) Pub Date : 2020-10-14 , DOI: 10.1158/1940-6207.capr-20-0217
Rasika Hudlikar 1 , Lujing Wang 1, 2 , Renyi Wu 1 , Shanyi Li 1 , Rebecca Peter 1, 2 , Ahmad Shannar 1, 2 , Pochung Jordan Chou 1, 2 , Xia Liu 1, 3 , Zhigang Liu 1, 4 , Hsiao-Chen Dina Kuo 1, 2 , Ah-Ng Kong 1
Affiliation  

Cancer is a complex disease and cancer development takes 10-50 years involving epigenetics. Evidence suggests that ~80% of human cancers are linked to environmental factors impinging upon genetics/epigenetics. Since advanced metastasized cancers are resistant to radiation/chemotherapeutic drugs, cancer prevention by relatively non-toxic chemopreventive "epigenetic modifiers" involving epigenetics/epigenomics is logical. Isothiocyanates are relatively non-toxic at low nutritional and even higher pharmacological doses, with good oral bioavailability, potent anti-oxidative stress/anti-inflammatory activities, possess epigenetic modifying properties, great anti-cancer efficacy in many in vitro cell culture and in vivo animal models. This review summarizes the latest advances on the role of epigenetics/epigenomics by isothiocyanates in prevention of skin, colon, lung, breast, and prostate cancers. The exact molecular mechanism how isothiocyanates modify the epigenetic/epigenomic machinery is unclear. We postulate "redox" processes would play important roles. Additionally, isothiocyanates sulforaphane and phenethyl-isothiocyanate, possess multifaceted molecular mechanisms would be considered as "general" cancer preventive agents not unlike chemotherapeutic agents like platinum-based or taxane-based drugs. Analogous to chemotherapeutic agents, the isothiocyanates would need to be used in combination with other non-toxic chemopreventive phytochemicals or drugs such as NSAIDs, 5 α reductase/aromatase inhibitors targeting different signaling pathways would be logical for the prevention of progression of tumors to late advanced metastatic states.

中文翻译:

表观遗传学/表观基因组学和异硫氰酸酯预防早期癌症

癌症是一种复杂的疾病,癌症的发展需要 10-50 年的时间,涉及表观遗传学。有证据表明,约 80% 的人类癌症与影响遗传学/表观遗传学的环境因素有关。由于晚期转移性癌症对放射/化学治疗药物具有抗性,因此通过涉及表观遗传学/表观基因组学的相对无毒的化学预防“表观遗传修饰剂”来预防癌症是合乎逻辑的。异硫氰酸酯在低营养甚至更高的药理剂量下相对无毒,具有良好的口服生物利用度,有效的抗氧化应激/抗炎活性,具有表观遗传修饰特性,在许多体外细胞培养和体内具有良好的抗癌功效动物模型。本综述总结了异硫氰酸酯在预防皮肤癌、结肠癌、肺癌、乳腺癌和前列腺癌中的表观遗传学/表观基因组学作用的最新进展。异硫氰酸酯如何修饰表观遗传/表观基因组机制的确切分子机制尚不清楚。我们假设“氧化还原”过程将发挥重要作用。此外,异硫氰酸酯萝卜硫素和苯乙基异硫氰酸酯具有多方面的分子机制,与铂类或紫杉烷类药物等化学治疗剂不同,被认为是“通用”癌症预防剂。与化学治疗剂类似,异硫氰酸酯需要与其他无毒化学预防性植物化学物质或药物(例如 NSAIDs)联合使用,
更新日期:2020-10-14
down
wechat
bug